Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                Biosimilars

Biosimilars

                        Biosimilar Basics for Patients
          Overview for Health Care Professionals
          Review and Approval
          Biological Product Innovation and Competition
          Biosimilar Product Information
          Biosimilars | Science and Research
          Industry Information and Guidance
          Curriculum Materials for Health Care Degree Programs | Biosimilars
          Multimedia Education Materials | Biosimilars Home
          Drugs
          Development & Approval Process | Drugs
          How Drugs are Developed and Approved
          Types of Applications
          Therapeutic Biologics Applications (BLA)
          Biosimilars
          Overview for Health Care ProfessionalsBiosimilars Overview for Health Care Professionals
  
  	
    Share
    Post
    Linkedin

    Email
    PrintDownload the fact sheet for health care providers: Overview of Biosimilar Products

Explore our educational materials for health care professionals: Curriculum Materials for Health Care Degree Programs

Biosimilars approved by the FDA are safe and effective biological medications. The availability of biosimilars can provide patients with more treatment options, increase access to lifesaving medications, and potentially lower health care costs through competition.

**Learn more about biological products, including biosimilars and interchangeable biosimilars:**

What is a biological product?
	What is a biosimilar product?
	Are biosimilars the same as generic drugs?
	How does FDA review and approve biosimilars?
	What is the difference between a biosimilar and an interchangeable biosimilar?**What is a biological product?**

Biological products, or biologics, are used to treat many illnesses, including chronic skin diseases, such as psoriasis; inflammatory bowel diseases, such as Crohn’s disease and ulcerative colitis; arthritis; kidney conditions; diabetes; and cancer.
	Biologics are generally large, complex molecules that are made from living sources such as bacteria, yeast, and animal cells.
	Because they generally come from living organisms, biologics inherently contain many slight variations from batch to batch, and their structures are generally more complex than those of other medications. As a result, biologics are often more complicated to purify, process, and manufacture.
	There are many types of biologics approved for use in the United States, such as monoclonal antibodies, insulin, vaccines, and allergenic products.

**Biosimilar Basics for Patients**
Find useful information on biologics and biosimilars for patients.

**What is a biosimilar product?**

A biosimilar is a biologic medication that is highly similar to and has no clinically meaningful differences from an existing FDA-approved biologic, called a reference product.

Compared with a reference product, biosimilars:
	Are made with the same types of living sources
		Are given to the patient in the same way
		Have the same strength, dosage, potential treatment benefits, and potential side effects
	A biosimilar may be used in patients who have previously been treated with the reference product (treatment-experienced), as well as in patients who have not previously received the reference product (treatment-naïve).**What Is a Biosimilar?**
View and download our infographic on biologics and biosimilars. 

**Are biosimilars the same as generic drugs?**

Biosimilars are like generic drugs in some ways, because both are versions of brand-name drugs and may offer patients more affordable treatment options.
	The main difference between biosimilars and generic drugs is that the active ingredients of generic drugs are generally smaller, simpler, and more straightforward to copy.
	Biologics generally cannot be copied exactly, because the products usually contain a mix of many slight variations of a protein, and this mix is never exactly the same in each dose or batch of the product.**How does FDA review and approve biosimilars?**

All FDA-approved biologics undergo a rigorous evaluation to help ensure their safety, effectiveness, and quality:

A reference product is approved in a stand-alone application that must contain data to demonstrate its safety and effectiveness, while a biosimilar is approved through an abbreviated pathway that generally avoids the need to conduct as many costly and lengthy clinical trials.
	A proposed biosimilar is compared to and evaluated against a reference product to verify that it is highly similar to and has no clinically meaningful differences in terms of safety, purity, and potency (i.e., safety and effectiveness) from the reference product.The biosimilar approval process provides assurance that biosimilars provide the same treatment benefits and risks as their respective reference products. Learn more about the biosimilar regulatory review and approval process.

**Prescribing Biosimilars and Interchangeable Biosimilars**
Learn more to inform prescription decisions. 

**What is the difference between a biosimilar and an interchangeable biosimilar?**

All FDA-approved biosimilars, including interchangeable biosimilars, must be highly similar to and have no clinically meaningful differences from the reference product in terms of safety and effectiveness. An interchangeable biosimilar is a biosimilar that meets additional requirements. A pharmacist may substitute an interchangeable biosimilar for its reference product without consulting the prescriber, depending on state pharmacy laws. FDA does not evaluate or approve a biosimilar as interchangeable unless a company requests it. Learn more about interchangeable biological products.



Updated FDA Labeling Recommendations for Biosimilar and Interchangeable Biosimilar Products

FDA has released its updated labeling guidance for biosimilar and interchangeable biosimilar products to include a “biosimilarity statement.” Learn more about this update from Sarah Yim, M.D., Director of the Office of New Drugs’ Office of Therapeutic Biologics and Biosimilars.

Read the full statement.En Español

                                                                                  Content current as of:
      01/18/2024
              
              
Regulated Product(s)
		 DrugsBiosimilars

          
                        Basics for Patients
          Overview for Health Care Professionals
          Review and Approval
          Biological Product Innovation and Competition
          Biosimilar Product Information
          Science and Research
          Industry Information and Guidance
          Curriculum Materials for Health Care Degree Programs
          Multimedia Education Materials
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop